published on August 15, 2017 by
In part one of a two-part series, Josh Johnston, OD discussed the paradigm shift in treating patients with dry eye. Here, he speaks to Primary Care Optometry News (PCON) about cryopreserved amniotic membrane and how it speeds healing.
In his last blog, Josh Johnston, OD, Georgia Eye Partners, spoke about the “Paradigm Shift in Treating Patients with Dry Eye” and how the introduction of new therapies allows doctors to provide better outcomes to patients and improve clinical outcomes. One of the therapies he spoke of is PROKERA with cryopreserved amniotic membrane, and its many benefits particularly for those patients with corneal involved dry eye.
Dr. Johnston recently spoke with Primary Care Optometry News (PCON) at Optometry’s meeting about this topic and how the use of cryopreserved amniotic membrane (PROKERA) speeds healing, helps with patient compliance and helps increase patient satisfaction. In regards to more severe patients Dr. Johnston says, “It’s (PROKERA) a good technology to help the cornea heal faster and help other therapeutics work quicker, and even simplify your treatment algorithm.”
He also spoke about how PROKERA has been a great addition to his Dry Eye Clinic as well as the many benefits of being a Bio-Tissue Dry Eye Center of Excellence (DECE).
You can view the PCON interview with Josh Johnston, OD “Amniotic Membrane Speeds Healing” here.
Josh Johnston, OD, FAAO practices at Georgia Eye Partners where he is Clinical Director, Residency Director and oversees the practice’s Dry Eye Clinic, one of Bio-Tissue’s Dry Eye Centers of Excellence (DECE). His clinical focus is on ocular surface disease, including dry eye and other corneal diseases, and his background includes extensive experience co-managing surgical patients before and after LASIK, cataract and other advanced corneal and refractive surgical procedures.